色素-话题@MedSci

#色素#

654篇内容 | 6222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680587, encodeId=b853168058e02, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=髋关节周围关节外色素沉着绒毛结节性滑膜囊炎二例, objectType=article, longId=156773, objectId=ad5e156e73fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad5e156e73fa, replyNumber=0, likeNumber=73, createdTime=2019-07-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad5e156e73fa, moduleTitle=髋关节周围关节外色素沉着绒毛结节性滑膜囊炎二例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad5e156e73fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680600, encodeId=8ffb16806009e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：黑色素瘤心脏转移-病例报道, objectType=article, longId=161377, objectId=107b1613e706, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=107b1613e706, replyNumber=0, likeNumber=77, createdTime=2019-07-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=107b1613e706, moduleTitle=NEJM：黑色素瘤心脏转移-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=107b1613e706)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680561, encodeId=e4c71680561cb, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Braftovi/Mektovi联合欧洲获批用于治疗BRAFV600突变的不可切除或转移性黑色素瘤, objectType=article, longId=149597, objectId=26f714959eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26f714959eaf, replyNumber=0, likeNumber=61, createdTime=2019-01-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26f714959eaf, moduleTitle=Braftovi/Mektovi联合欧洲获批用于治疗BRAFV600突变的不可切除或转移性黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26f714959eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680554, encodeId=84e7168055400, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：PHIP拷贝数作为皮肤黑色素瘤的预后及进展标志, objectType=article, longId=148368, objectId=7c951483681a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c951483681a, replyNumber=0, likeNumber=51, createdTime=2018-11-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c951483681a, moduleTitle=CLIN CANCER RES：PHIP拷贝数作为皮肤黑色素瘤的预后及进展标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c951483681a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680563, encodeId=77ec1680563ea, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果, objectType=article, longId=149967, objectId=b1e214996ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1e214996ea4, replyNumber=0, likeNumber=56, createdTime=2019-04-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1e214996ea4, moduleTitle=免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1e214996ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680619, encodeId=8b39168061939, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：伊匹单抗联合纳武单抗治疗III期黑色素瘤的更佳剂量方案, objectType=article, longId=167664, objectId=fffd16e664b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fffd16e664b7, replyNumber=0, likeNumber=97, createdTime=2019-12-23, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fffd16e664b7, moduleTitle=Lancet Oncol：伊匹单抗联合纳武单抗治疗III期黑色素瘤的更佳剂量方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fffd16e664b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680590, encodeId=cd8c168059012, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=AU-011治疗脉络膜黑色素瘤取得突破进展, objectType=article, longId=157811, objectId=75e415e8114d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75e415e8114d, replyNumber=0, likeNumber=81, createdTime=2019-07-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75e415e8114d, moduleTitle=AU-011治疗脉络膜黑色素瘤取得突破进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75e415e8114d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680594, encodeId=b9e91680594e1, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=PLoS One：免疫逃逸基因在葡萄膜黑色素瘤中的差异调节和预后表征, objectType=article, longId=159285, objectId=dc2e159285ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc2e159285ec, replyNumber=0, likeNumber=82, createdTime=2019-09-16, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc2e159285ec, moduleTitle=PLoS One：免疫逃逸基因在葡萄膜黑色素瘤中的差异调节和预后表征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc2e159285ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680543, encodeId=701916805434a, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Dermat：什么？这样做可将黑色素瘤风险降低40%！, objectType=article, longId=145318, objectId=0a6614531878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6614531878, replyNumber=0, likeNumber=80, createdTime=2019-04-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6614531878, moduleTitle=JAMA Dermat：什么？这样做可将黑色素瘤风险降低40%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a6614531878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680540, encodeId=ddc9168054035, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Oncotarget：减量保效！免疫治疗黑色素瘤纪实, objectType=article, longId=144510, objectId=ccaa1445105c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccaa1445105c, replyNumber=0, likeNumber=54, createdTime=2019-03-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccaa1445105c, moduleTitle=Oncotarget：减量保效！免疫治疗黑色素瘤纪实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccaa1445105c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680549, encodeId=f31a16805495f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：突破！联合免疫疗法显著缩小黑色素瘤的脑转移, objectType=article, longId=147592, objectId=a0e214e59261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e214e59261, replyNumber=0, likeNumber=81, createdTime=2019-05-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e214e59261, moduleTitle=NEJM：突破！联合免疫疗法显著缩小黑色素瘤的脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0e214e59261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680596, encodeId=2d2616805965d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=英国警示氢氯噻嗪非黑色素瘤皮肤癌风险, objectType=article, longId=159455, objectId=881c1594553f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=881c1594553f, replyNumber=0, likeNumber=78, createdTime=2019-03-18, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=881c1594553f, moduleTitle=英国警示氢氯噻嗪非黑色素瘤皮肤癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=881c1594553f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680586, encodeId=65c1168058663, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Rom J Ophthalmol：在中心浆液性脉络膜视网膜病变中的黄斑色素密度变化, objectType=article, longId=156607, objectId=3fbd15660e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fbd15660e52, replyNumber=0, likeNumber=48, createdTime=2019-07-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fbd15660e52, moduleTitle=Rom J Ophthalmol：在中心浆液性脉络膜视网膜病变中的黄斑色素密度变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fbd15660e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680576, encodeId=e57316805e676, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2018 AAD指南：原发性皮肤黑色素瘤的管理, objectType=article, longId=153472, objectId=67be1534e2d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67be1534e2d0, replyNumber=0, likeNumber=16, createdTime=2019-03-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67be1534e2d0, moduleTitle=2018 AAD指南：原发性皮肤黑色素瘤的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67be1534e2d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680614, encodeId=019c168061443, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：转移性葡萄膜黑色素瘤-病例报道, objectType=article, longId=165748, objectId=6d14165e48d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d14165e48d5, replyNumber=0, likeNumber=66, createdTime=2020-04-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d14165e48d5, moduleTitle=NEJM：转移性葡萄膜黑色素瘤-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d14165e48d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680541, encodeId=2619168054158, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NCCN临床实践指南：黑色素瘤（2018.V3）, objectType=article, longId=144581, objectId=b81314458126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81314458126, replyNumber=0, likeNumber=0, createdTime=2019-06-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81314458126, moduleTitle=NCCN临床实践指南：黑色素瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81314458126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680606, encodeId=acbf1680606fe, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定, objectType=article, longId=163663, objectId=4f8916366308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8916366308, replyNumber=0, likeNumber=68, createdTime=2019-05-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8916366308, moduleTitle=Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8916366308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680569, encodeId=2f221680569e5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=颈脊髓外硬膜下色素性神经鞘瘤1例, objectType=article, longId=151650, objectId=239415165042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=239415165042, replyNumber=0, likeNumber=66, createdTime=2019-07-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=239415165042, moduleTitle=颈脊髓外硬膜下色素性神经鞘瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=239415165042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680584, encodeId=38ce1680584a0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Ophthalmol：青少年和儿童阶段的葡萄膜黑色素瘤综述, objectType=article, longId=155961, objectId=d317155961af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d317155961af, replyNumber=0, likeNumber=60, createdTime=2019-09-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d317155961af, moduleTitle=Clin Ophthalmol：青少年和儿童阶段的葡萄膜黑色素瘤综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d317155961af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680589, encodeId=aadd168058914, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Bone Miner Metab：色素上皮衍生因子（PEDF）降低骨外植体培养物中SOST/硬化蛋白的表达和合成, objectType=article, longId=157560, objectId=5a0f15e560b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0f15e560b2, replyNumber=0, likeNumber=49, createdTime=2019-05-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0f15e560b2, moduleTitle=J Bone Miner Metab：色素上皮衍生因子（PEDF）降低骨外植体培养物中SOST/硬化蛋白的表达和合成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0f15e560b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

髋关节周围关节外色素沉着绒毛结节性滑膜囊炎二例

2019-07-24

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：黑色素瘤心脏转移-病例报道

2019-07-24

sunylz (审核中...)

前往app查看评论内容

#色素#

Braftovi/Mektovi联合欧洲获批用于治疗BRAFV600突变的不可切除或转移性黑色素瘤

2019-01-08

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：PHIP拷贝数作为皮肤黑色素瘤的预后及进展标志

2018-11-03

sunylz (审核中...)

前往app查看评论内容

#色素#

免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果

2019-04-16

docwu2019 (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：伊匹单抗联合纳武单抗治疗III期黑色素瘤的更佳剂量方案

2019-12-23

sunylz (审核中...)

前往app查看评论内容

#色素#

AU-011治疗脉络膜黑色素瘤取得突破进展

2019-07-05

智智灵药 (审核中...)

前往app查看评论内容

#色素#

PLoS One：免疫逃逸基因在葡萄膜黑色素瘤中的差异调节和预后表征

2019-09-16

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Dermat：什么？这样做可将黑色素瘤风险降低40%！

2019-04-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Oncotarget：减量保效！免疫治疗黑色素瘤纪实

2019-03-03

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：突破！联合免疫疗法显著缩小黑色素瘤的脑转移

2019-05-21

sunylz (审核中...)

前往app查看评论内容

#色素#

英国警示氢氯噻嗪非黑色素瘤皮肤癌风险

2019-03-18

sunylz (审核中...)

前往app查看评论内容

#色素#

Rom J Ophthalmol：在中心浆液性脉络膜视网膜病变中的黄斑色素密度变化

2019-07-12

sunylz (审核中...)

前往app查看评论内容

#色素#

2018 AAD指南：原发性皮肤黑色素瘤的管理

2019-03-16

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：转移性葡萄膜黑色素瘤-病例报道

2020-04-19

sunylz (审核中...)

前往app查看评论内容

#色素#

NCCN临床实践指南：黑色素瘤（2018.V3）

2019-06-24

sunylz (审核中...)

前往app查看评论内容

#色素#

Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定

2019-05-24

sunylz (审核中...)

前往app查看评论内容

#色素#

颈脊髓外硬膜下色素性神经鞘瘤1例

2019-07-31

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Ophthalmol：青少年和儿童阶段的葡萄膜黑色素瘤综述

2019-09-04

sunylz (审核中...)

前往app查看评论内容

#色素#

J Bone Miner Metab：色素上皮衍生因子（PEDF）降低骨外植体培养物中SOST/硬化蛋白的表达和合成

2019-05-22

科室
- - 订阅+
  - 更多科室
工具
服务